tiprankstipranks

New Portfolio - New Portfolio

Adi Rahim

New Portfolio
Individual Investor
Ranked #552,703 out of 730,641 TipRanks' Investors
Success Rate
32%
46 out of 144
profitable transactions
Average Return
-18.42%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 11.62%
6-Month Return▲ 19.25%
12-Month Return▼ 5.42%
YTD Return▼ 10.25%
Total Return▲ 62.33%

Best Trade

Opened at
Closed at-
Gain▲ 762.07%

Bio

Healthcare Sector

Performance

14.08%0-14.08%
▼ 4.52%
▼ 4.74%
▼ 6.89%
Sep 2023
▼ 6.45%
▼ 2.17%
▼ 13.06%
Oct 2023
▲ 9.22%
▲ 9.13%
▲ 13.10%
Nov 2023
▲ 5.14%
▲ 4.57%
▲ 14.08%
Dec 2023
▼ 1.87%
▲ 1.59%
▼ 2.23%
Jan 2024
▲ 14.08%
▲ 5.22%
▲ 6.81%
Feb 2024
▲ 5.05%
▲ 3.27%
▼ 2.75%
Mar 2024
▼ 11.79%
▼ 2.83%
▼ 11.62%
Apr 2024
TipRanks AverageS&P 500Investor Portfolio
▼ 4.52%▼ 4.74%▼ 6.89%
▼ 6.45%▼ 2.17%▼ 13.06%
▲ 9.22%▲ 9.13%▲ 13.10%
▲ 5.14%▲ 4.57%▲ 14.08%
▼ 1.87%▲ 1.59%▼ 2.23%
▲ 14.08%▲ 5.22%▲ 6.81%
▲ 5.05%▲ 3.27%▼ 2.75%
▼ 11.79%▼ 2.83%▼ 11.62%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
37go5xg
37go5xg
37go5xg
37go5xg
37go5xg
37go5xg
37go5xg
frq3cnh716i
frq3cnh716i
frq3cnh716i
frq3cnh716i
frq3cnh716i
frq3cnh716i
frq3cnh716i
a8ewo624rww
a8ewo624rww
a8ewo624rww
a8ewo624rww
a8ewo624rww
a8ewo624rww
a8ewo624rww
ng8an90vp79
ng8an90vp79
ng8an90vp79
ng8an90vp79
ng8an90vp79
ng8an90vp79
ng8an90vp79
zt0vfprb6be
zt0vfprb6be
zt0vfprb6be
zt0vfprb6be
zt0vfprb6be
zt0vfprb6be
zt0vfprb6be
oprdou8svb
oprdou8svb
oprdou8svb
oprdou8svb
oprdou8svb
oprdou8svb
oprdou8svb
rz6zrn
rz6zrn
rz6zrn
rz6zrn
rz6zrn
rz6zrn
rz6zrn
o31xp0qi75
o31xp0qi75
o31xp0qi75
o31xp0qi75
o31xp0qi75
o31xp0qi75
o31xp0qi75
cvotur
cvotur
cvotur
cvotur
cvotur
cvotur
cvotur
qyi1zhxj1xe
qyi1zhxj1xe
qyi1zhxj1xe
qyi1zhxj1xe
qyi1zhxj1xe
qyi1zhxj1xe
qyi1zhxj1xe
To view investors' portfolios
Sign Up For Free
Axcella Health
▼ 99.72%
2
Close
Dec 29, 2023
Allena Pharmaceuticals
▼ 99.25%
2
Close
Dec 14, 2023
eMagin
▲ 127.47%
2
Close
Oct 17, 2023
Bed Bath & Beyond
▼ 99.64%
2
Close
Oct 02, 2023
Amryt Pharma
▲ 52.65%
2
Close
Apr 11, 2023
Opiant Pharmaceuticals
▲ 57.39%
2
Close
Mar 02, 2023
Tyme Technologies
▼ 75.59%
2
Close
Sep 16, 2022
Syros Pharmaceuticals
0%
▼ 31.42%
1
Open
Sep 16, 2022
Antares Pharma
▲ 54.85%
2
Close
May 24, 2022
Intricon
▲ 12.53%
3
Close
May 24, 2022
Aytu BioScience
0%
▼ 98.51%
1
Open
Mar 19, 2021
Prophase Labs
0%
▼ 31.87%
1
Open
Mar 01, 2021
Can-Fite BioPharma
0%
▼ 90.20%
1
Open
Mar 01, 2021
Elicio Therapeutics
0%
▼ 95.49%
1
Open
Mar 01, 2021
Seabridge Gold
0%
▼ 14.94%
1
Open
Feb 24, 2021
InMed Pharmaceuticals
0%
▼ 99.81%
1
Open
Feb 17, 2021
Moleculin Biotech
0%
▼ 93.86%
1
Open
Feb 17, 2021
Cidara Therapeutics
0%
▼ 75.24%
1
Open
Feb 12, 2021
Hyrecar
0%
▼ 99.92%
1
Open
Feb 10, 2021
Antibe Therapeutics
0%
▼ 95.42%
1
Open
Feb 10, 2021